Search - tctmd.com

Displaying 21 - 40 of 52

Sort: Relevancy | Date

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

News Conference News SCAI 2016

Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding

May 05, 2016

News Daily News

Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados

Yael L. Maxwell

April 25, 2016

News Daily News

A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes

Yael L. Maxwell

April 25, 2016

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

Presentation

Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy

Presenter: MB. Kadakia

December 20, 2015

News Daily News

Radial-Access Associated with One-Third Less Bleeding in Rescue PCI After Fibrinolysis

Michael O'Riordan

December 20, 2015

News Daily News

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

December 14, 2015

News Daily News

Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI

December 14, 2015

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

December 14, 2015

News Daily News

经桡动脉PCI可能会减弱比伐卢定的益处

October 05, 2015

News Daily News

Transradial PCI May Attenuate Bivalirudin Benefits

October 05, 2015

News Daily News

PCI Transradial podría atenuar los beneficios de la bivalirudina

October 05, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

News Daily News

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

April 28, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

March 17, 2015

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

January 15, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.